MedPath
NMPA Approval

Recombinant Human Interferon α2b for Injection

国药准字S20063024

July 10, 2020

Drug Information

注射用重组人干扰素α2b

莱福隆

莱福隆

注射剂

500万单位

生物制品

July 10, 2020

Company Information

Applicant Company

浙江省东阳市江北高科技工业园区

Manufacturing Company

浙江省东阳市江北高科技工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用重组人干扰素α2b - NMPA 批准文号 | MedPath